Impact of Comprehensive Rehabilitation Nursing Combined With Refined Airway Management and Nutritional Support on Prognosis and Care Delivery Models in Critically Ill Patients
1 other identifier
interventional
101
1 country
1
Brief Summary
This combined intervention protocol effectively improves the prognosis of critically ill patients and optimizes nursing management models
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 2, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 5, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 23, 2024
CompletedFirst Submitted
Initial submission to the registry
June 9, 2025
CompletedFirst Posted
Study publicly available on registry
June 18, 2025
CompletedJune 18, 2025
June 1, 2025
1 year
June 9, 2025
June 17, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
ICU Length of Stay (LOS)
Calendar days from ICU admission to discharge criteria met (APACHE II score ≤10, hemodynamic stability for ≥24h).
From randomization to ICU discharge, up to 60 days
Secondary Outcomes (1)
Incidence of Pulmonary Infections
From ICU admission to 48 hours post-extubation or 14-day intervention period
Other Outcomes (1)
Protocol Adherence Rate
Daily during 14-day intervention
Study Arms (2)
control group
OTHERintervention group
EXPERIMENTALInterventions
The Standard Critical Care Nursing Protocol encompasses evidence-based, routine nursing practices for critically ill patients in the intensive care unit (ICU). This protocol serves as the control intervention in comparative studies evaluating novel nursing strategies. Key Components: Basic Physiological Monitoring: Continuous assessment of vital signs (heart rate, blood pressure, respiratory rate, SpO₂). Strict intake/output monitoring and electrolyte balance management. Airway Management: Standard oxygen therapy (nasal cannula, face mask) or mechanical ventilation as prescribed. Scheduled suctioning, positional changes, and oral care (every 4-6 hours). Infection Prevention: Aseptic techniques for invasive procedures (e.g., central line care, urinary catheter management). Ventilator-associated pneumonia (VAP) bundle compliance (e.g., head-of-bed elevation, sedation vacations). Mobility \& Skin Integrity: Passive range-of-motion exercises for immobilized patients (2×/day). Pr
The intervention group received a standardized 14-day nursing protocol combining three evidence-based components: Comprehensive Rehabilitation Nursing: Early mobilization protocol with passive/active exercises (3-4 sessions/day) Respiratory training using incentive spirometry (Triflo II® devices) Swallowing rehabilitation with VitalStim® electrical stimulation Refined Airway Management: Humidification via Fisher \& Paykel® MR850 systems (33-44 mg/L) Closed suction systems (Ballard® Trach Care) with strict aseptic technique Oral care with 0.12% chlorhexidine solution (Peridex®) 4×/day Nutritional Support: Enteral feeding using Abbott Nutrition® formulas Parenteral nutrition via Baxter®/Fresenius Kabi® solutions Gastric residual monitoring with Kangaroo™ feeding pumps Key Features: Implemented by specialized ICU nurses, respiratory therapists, and dietitians Daily monitoring using Philips® IntelliVue patient monitors Protocol adjustments based on weekly APACHE II scoring
Eligibility Criteria
You may qualify if:
- Fulfillment of ICU admission standards with critical illness confirmed by attending physicians or senior specialists
- Age ≥ 18 years
- Stable vital signs:
- Systolic blood pressure ≥ 90 mmHg and ≤ 180 mmHg
- Heart rate ≤ 120 beats/min
- Oxygen saturation (SpO₂) ≥ 85% under ≤ 60% fraction of inspired oxygen (FiO₂)
- Intact or tolerable gastrointestinal (GI) function for enteral nutrition
You may not qualify if:
- Terminal malignancies
- Brain death
- Irreversible organ failure (e.g., end-stage cirrhosis, advanced heart failure)
- Comorbidities potentially confounding study outcomes
- Contraindications to interventions (e.g., laryngeal edema, complete intestinal obstruction)
- Pregnancy or lactation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Taizhou Hospital of Traditional Chinese Medicine
Taizhou, Jiangsu, 225300, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 9, 2025
First Posted
June 18, 2025
Study Start
June 2, 2023
Primary Completion
June 5, 2024
Study Completion
June 23, 2024
Last Updated
June 18, 2025
Record last verified: 2025-06